0,968  0,002  Aldehyde oxidase inhibitor
0,890  0,004  CYP1A2 inhibitor
0,888  0,004  CYP1A2 substrate
0,868  0,003  CTGF expression inhibitor
0,855  0,003  NOS2 expression inhibitor
0,849  0,004  12-Lipoxygenase inhibitor
0,836  0,005  15-Lipoxygenase inhibitor
0,830  0,007  Caspase 9 stimulant
0,827  0,005  Aryl hydrocarbon receptor agonist
0,814  0,004  AR expression inhibitor
0,813  0,003  Antimutagenic
0,789  0,008  CYP2C9 substrate
0,781  0,003  UGT1A3 substrate
0,738  0,004  UGT1A1 substrate
0,733  0,003  Aldehyde dehydrogenase inhibitor
0,726  0,006  CYP2C19 substrate
0,722  0,004  MAO inhibitor
0,724  0,008  Chemoprotective
0,720  0,005  Lipoxygenase inhibitor
0,710  0,004  MAO A inhibitor
0,705  0,005  Caspase 3 stimulant
0,700  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,691  0,002  Macrophage migration inhibitory factor inhibitor
0,709  0,029  Apoptosis agonist
0,683  0,007  UGT1A9 substrate
0,672  0,007  Antioxidant
0,667  0,005  CYP2C19 inhibitor
0,663  0,007  NOS3 expression inhibitor
0,659  0,003  Melanin inhibitor
0,654  0,011  Chemopreventive
0,645  0,004  MAO B inhibitor
0,638  0,004  Breast cancer-resistant protein inhibitor
0,632  0,008  Cardioprotectant
0,634  0,013  Radioprotector
0,625  0,004  NOS3 expression enhancer
0,646  0,028  Antineoplastic (breast cancer)
0,622  0,009  CYP2C9 inhibitor
0,623  0,011  Antineoplastic (melanoma)
0,624  0,015  Antihypercholesterolemic
0,613  0,008  Antineoplastic (glioma)
0,630  0,028  Transcription factor NF kappa B inhibitor
0,610  0,008  Free radical scavenger
0,601  0,005  Monophenol monooxygenase inhibitor
0,603  0,008  Ulceration
0,637  0,046  Alpha-glucosidase inhibitor
0,614  0,022  Antineoplastic (colorectal cancer)
0,610  0,021  Antineoplastic (colon cancer)
0,608  0,028  CYP3A4 substrate
0,576  0,005  Pyruvate kinase inhibitor
0,573  0,004  NADPH oxidase inhibitor
0,582  0,014  CYP2D6 substrate
0,573  0,009  Amyloid beta aggregation inhibitor
0,567  0,005  Sulfotransferase substrate
0,566  0,009  Vasodilator, coronary
0,586  0,032  Antineoplastic (lung cancer)
0,564  0,022  Prostate cancer treatment
0,549  0,016  Cytostatic
0,549  0,016  Histamine release inhibitor
0,547  0,016  Proliferative diseases treatment
0,549  0,020  Bone diseases treatment
0,536  0,010  UDP-glucuronosyltransferase substrate
0,555  0,030  Antileukemic
0,527  0,008  Peroxidase inhibitor
0,520  0,012  UGT1A6 substrate
0,503  0,004  UGT2B15 substrate
0,516  0,018  Antiosteoporotic
0,517  0,020  Antineoplastic (cervical cancer)
0,500  0,004  CYP2B6 inhibitor
0,505  0,010  UGT2B4 substrate
0,510  0,017  Antineoplastic (non-small cell lung cancer)
0,497  0,004  Pneumotoxic
0,531  0,039  TNF expression inhibitor
0,498  0,006  Amylase inhibitor
0,482  0,008  Skin whitener
0,512  0,039  Prostaglandin dehydrogenase inhibitor
0,476  0,007  Topoisomerase II inhibitor
0,470  0,003  Histidine decarboxylase inhibitor
0,504  0,038  Antiparkinsonian
0,470  0,007  Antihypotensive
0,479  0,017  Antineoplastic (glioblastoma multiforme)
0,482  0,025  Carcinogenic
0,466  0,014  Antineoplastic (osteosarcoma)
0,484  0,038  5 Hydroxytryptamine release inhibitor
0,450  0,008  Bone formation stimulant
0,445  0,005  Antineoplastic (bone cancer)
0,448  0,010  Tubulin antagonist
0,456  0,018  Superoxide dismutase inhibitor
0,442  0,009  Genotoxic
0,432  0,004  Xanthine oxidase inhibitor
0,449  0,021  Antiamyloidogenic
0,414  0,005  Cystathionine beta-synthase inhibitor
0,434  0,026  Mutagenic
0,429  0,022  Nitric oxide antagonist
0,441  0,036  Antineoplastic (ovarian cancer)
0,423  0,019  Antihypoxic
0,405  0,003  VEGF expression inhibitor
0,405  0,004  Antineoplastic (uterine cancer)
0,426  0,032  Apoptosis antagonist
0,422  0,034  Antineoplastic (brain cancer)
0,393  0,007  Acetylcholinesterase inhibitor
0,390  0,004  Succinate dehydrogenase inhibitor
0,395  0,012  Carcinogenic, group 3
0,408  0,026  Tumour necrosis factor alpha release inhibitor
0,407  0,028  Antiprotozoal (Leishmania)
0,408  0,030  CYP3A4 inhibitor
0,380  0,005  Antiprotozoal (Coccidial)
0,379  0,006  Alkaline phosphatase inhibitor
0,392  0,025  Antineoplastic (renal cancer)
0,423  0,058  Antipruritic, allergic
0,393  0,030  DNA damaging
0,377  0,016  GST M1-1 substrate
0,413  0,052  Thioredoxin glutathione reductase inhibitor
0,364  0,004  Estrogen receptor alpha antagonist
0,356  0,003  CF transmembrane conductance regulator agonist
0,371  0,019  P-glycoprotein inhibitor
0,355  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,373  0,025  Antihypertriglyceridemic
0,455  0,108  Antiinflammatory
0,362  0,017  Hepatoprotectant
0,387  0,043  Spasmolytic
0,350  0,009  Amyloid beta precursor protein antagonist
0,343  0,005  Topoisomerase II alpha inhibitor
0,339  0,003  Papain-like protease (SARS coronavirus) inhibitor
0,338  0,002  SULT1E1 substrate
0,368  0,034  Antipyretic
0,334  0,002  DOPA decarboxylase inhibitor
0,336  0,005  Beta glucuronidase inhibitor
0,353  0,022  UGT1A4 substrate
0,339  0,009  Heat shock protein 90 alpha antagonist
0,333  0,004  Interleukin 5 antagonist
0,341  0,014  Cholinergic
0,342  0,016  Mcl-1 antagonist
0,338  0,014  Lipid peroxidase inhibitor
0,358  0,036  Hypoglycemic
0,329  0,018  DNA methyltransferase I inhibitor
0,311  0,004  Postmenopausal disorders treatment
0,314  0,008  Heat shock protein 90 antagonist
0,335  0,030  5 Hydroxytryptamine uptake stimulant
0,312  0,009  UGT2B9 substrate
0,359  0,059  FMO1 substrate
0,336  0,037  Vascular (periferal) disease treatment
0,320  0,022  UGT2B7 substrate
0,382  0,085  Antibacterial
0,315  0,020  Antialcoholic
0,348  0,052  Antineoplastic (pancreatic cancer)
0,327  0,032  Antineoplastic (bladder cancer)
0,354  0,060  ICAM1 expression inhibitor
0,350  0,056  Respiratory analeptic
0,369  0,076  GABA C receptor rho-3 antagonist
0,323  0,032  Antineoplastic (sarcoma)
0,296  0,006  Estrogen antagonist
0,297  0,009  Antiviral (West Nile virus)
0,306  0,018  Protein-tyrosine phosphatase inhibitor
0,325  0,040  Vasodilator
0,321  0,039  Antimitotic
0,307  0,026  DNA methylase inhibitor
0,287  0,005  Alcohol dehydrogenase inhibitor
0,327  0,047  Antiprotozoal (Trypanosoma)
0,285  0,005  Estrogen receptor beta antagonist
0,399  0,120  DNA polymerase beta inhibitor
0,318  0,043  Angiogenesis stimulant
0,319  0,044  Transcription factor STAT3 inhibitor
0,358  0,083  GST A substrate
0,298  0,024  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,296  0,023  Antiseptic
0,336  0,065  Hepatic disorders treatment
0,299  0,032  RNA-directed DNA polymerase inhibitor
0,294  0,027  VCAM1 expression inhibitor
0,286  0,020  Antineoplastic (gastric cancer)
0,273  0,012  Carcinogenic, group 2B
0,270  0,013  5-Lipoxygenase inhibitor
0,305  0,049  Antineoplastic (liver cancer)
0,264  0,010  UGT2B10 substrate
0,277  0,024  I kappa B kinase epsilon inhibitor
0,261  0,011  Carbonic anhydrase XV inhibitor
0,281  0,032  Dual specificity phosphatase inhibitor
0,286  0,038  Platelet adhesion inhibitor
0,264  0,018  M18 aspartyl aminopeptidase inhibitor
0,285  0,038  Abortion inducer
0,273  0,028  Antipruritic, non-allergic
0,258  0,016  Carcinogenic, group 1
0,253  0,011  Mannose-6-phosphate isomerase inhibitor
0,256  0,016  Topoisomerase I inhibitor
0,252  0,012  Neurotrophic factor
0,244  0,006  Estrogen agonist
0,260  0,023  Phospholipase C inhibitor
0,366  0,131  DNA directed DNA polymerase inhibitor
0,242  0,007  Photosensitizer
0,251  0,017  Antifungal enhancer
0,249  0,017  Protein-tyrosine phosphatase 1B inhibitor
0,292  0,060  Transcription factor STAT inhibitor
0,247  0,015  Butyrylcholinesterase inhibitor
0,235  0,004  Xanthine dehydrogenase inhibitor
0,278  0,050  Antiparasitic
0,229  0,005  Multidrug resistance-associated protein 1 inhibitor
0,229  0,008  Antihelmintic (Trematoda)
0,225  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,236  0,015  Antihemorrhagic
0,228  0,007  Gastritis treatment
0,231  0,011  Telomerase inhibitor
0,233  0,013  Toll-Like receptor 2 antagonist
0,227  0,007  MAP kinase kinase 4 inhibitor
0,255  0,043  Antihelmintic
0,293  0,082  Streptokinase A inhibitor
0,291  0,080  Analeptic
0,223  0,014  SULT1A1 substrate
0,265  0,056  Interleukin antagonist
0,219  0,011  Contraceptive female
0,299  0,094  Thyroid hormone antagonist
0,212  0,007  DNA repair enzyme inhibitor
0,276  0,075  Insulysin inhibitor
0,260  0,059  Cytotoxic
0,239  0,040  Nitric-oxide synthase stimulant
0,221  0,023  SULT1A3 substrate
0,217  0,018  Antibacterial (Helicobacter pylori)
0,213  0,017  Interleukin 1b antagonist
0,257  0,062  Tyrosine 3 hydroxylase inhibitor
0,207  0,015  Carbonic anhydrase III inhibitor
0,206  0,013  Carbonic anhydrase XIII inhibitor
0,213  0,022  Chelator
0,209  0,019  Expectorant
0,336  0,146  MAP kinase 1 inhibitor
0,198  0,009  Aromatase inhibitor
0,198  0,010  Carcinogenic, group 2A
0,223  0,037  Antineoplastic (squamous cell carcinoma)
0,205  0,019  Endometrios treatment
0,193  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,249  0,067  Sensitization
0,222  0,042  Histone acetyltransferase inhibitor
0,192  0,014  Dementia treatment
0,224  0,049  Dual specificity phosphatase 3 inhibitor
0,240  0,066  MAP-kinase-activated kinase 5 inhibitor
0,244  0,071  Cardiodepressant
0,187  0,014  Vascular dementia treatment
0,210  0,038  Protein kinase stimulant
0,233  0,063  Antineoplastic enhancer
0,182  0,014  Antiviral (Influenza B)
0,199  0,033  Interleukin 1 antagonist
0,179  0,013  Urease inhibitor
0,201  0,035  Hexokinase inhibitor
0,206  0,041  Antiviral (Influenza A)
0,202  0,040  Interferon gamma antagonist
0,175  0,015  Protein kinase C zeta inhibitor
0,248  0,088  Radiosensitizer
0,167  0,008  Alpha tubulin antagonist
0,207  0,048  LDLR expression enhancer
0,168  0,010  Beta tubulin antagonist
0,269  0,112  Cholesterol antagonist
0,215  0,060  Non-steroidal antiinflammatory agent
0,196  0,043  Antirickettsial
0,229  0,077  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,181  0,030  GST P1-1 substrate
0,182  0,031  Gout treatment
0,168  0,017  Creatine kinase inhibitor
0,154  0,005  Fatty acid synthase inhibitor
0,194  0,046  Antineoplastic (carcinoma)
0,167  0,020  Heat shock protein 70 antagonist
0,187  0,040  Aldose reductase substrate
0,178  0,031  Interleukin 4 antagonist
0,163  0,018  Carbonic anhydrase VI inhibitor
0,177  0,032  Glutathione S-transferase substrate
0,189  0,044  Arachidonic acid antagonist
0,190  0,046  Phobic disorders treatment
0,154  0,010  Aldose reductase inhibitor
0,298  0,156  Transcription factor inhibitor
0,195  0,055  3C-like protease (Human coronavirus) inhibitor
0,261  0,125  Antineoplastic (small cell lung cancer)
0,159  0,025  UGT2B1 substrate
0,251  0,118  Thyroid hormone beta antagonist
0,152  0,019  Antifungal (Pneumocystis)
0,205  0,072  Neurotrophic factor enhancer
0,152  0,020  Electron transport complex I inhibitor
0,140  0,007  Granulocyte macrophage colony stimulating factor agonist
0,147  0,016  UGT2B11 substrate
0,143  0,013  HIV-1 integrase (Strand Transfer) inhibitor
0,137  0,008  Estrogen receptor beta agonist
0,242  0,114  Antimycobacterial
0,174  0,047  GABA C receptor rho-2 antagonist
0,144  0,018  CYP2A6 inhibitor
0,297  0,170  Alzheimer's disease treatment
0,200  0,074  Antiviral (Influenza)
0,218  0,093  Cardiovascular analeptic
0,149  0,024  Uric acid excretion stimulant
0,179  0,055  Death-associated protein kinase 2 inhibitor
0,215  0,090  Dyrk kinase inhibitor
0,174  0,052  Insulin secretagoues
0,238  0,118  Antifungal
0,147  0,030  Aldehyde dehydrogenase substrate
0,122  0,005  Potassium channel Kv1.3 blocker
0,157  0,041  Cholesterol synthesis inhibitor
0,154  0,038  Beta amyloid protein antagonist
0,165  0,050  Cyclooxygenase 1 inhibitor
0,194  0,079  Insulin sensitizer
0,122  0,007  CD45 antagonist
0,118  0,005  Glutamate (mGluR7) antagonist
0,228  0,114  Antineoplastic (multiple myeloma)
0,179  0,068  Tumour necrosis factor antagonist
0,202  0,092  Cyclic AMP phosphodiesterase inhibitor
0,169  0,062  Cyclin-dependent kinase 3 inhibitor
0,119  0,012  Phosphodiesterase VI inhibitor
0,108  0,004  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,259  0,156  Antiprotozoal
0,122  0,019  Myeloperoxidase inhibitor
0,228  0,126  FMO3 substrate
0,198  0,095  Teratogen
0,114  0,012  CDC25B inhibitor
0,116  0,015  D-Ala-D-Ala ligase inhibitor
0,106  0,005  Postcoital contraceptive
0,160  0,062  Cyclooxygenase inhibitor
0,099  0,003  Estrogen-related receptor beta antagonist
0,135  0,040  HDL-cholesterol increasing
0,099  0,007  Transcription factor RelA inhibitor
0,129  0,036  Potassium channel (Ca-activated) activator
0,112  0,021  Lipase inhibitor
0,244  0,154  Calcium channel activator
0,114  0,024  Keratolytic
0,133  0,043  Mucolytic
0,131  0,042  Antischistosomal
0,109  0,020  HIV-1 integrase inhibitor
0,097  0,009  Estrogen receptor alpha agonist
0,119  0,031  ABCA1 expression enhancer
0,140  0,052  Proteasome inhibitor
0,208  0,121  5 Hydroxytryptamine 1E antagonist
0,108  0,022  Leukotriene synthesis inhibitor
0,189  0,104  Antineoplastic (lymphoma)
0,142  0,058  Antiprotozoal (Trichomonas)
0,091  0,010  Carbonic anhydrase VII inhibitor
0,201  0,121  5 Hydroxytryptamine release stimulant
0,180  0,102  Antiviral (Ebola)
0,157  0,080  Antihelmintic (Nematodes)
0,178  0,101  Embryotoxic
0,122  0,047  AMP-activated protein kinase stimulant
0,132  0,057  Coagulant
0,142  0,068  Contraceptive
0,101  0,027  CDC25A inhibitor
0,120  0,047  Antiinfertility, female
0,129  0,057  Sphingosine 1-phosphate receptor 4 antagonist
0,113  0,041  Antineoplastic antibiotic
0,141  0,070  Ca2+-transporting ATPase inhibitor
0,209  0,139  CYP2D6 inhibitor
0,143  0,075  Adenylate cyclase stimulant
0,225  0,156  Sodium/bile acid cotransporter inhibitor
0,157  0,089  Aldehyde oxidase substrate
0,120  0,053  Choleretic
0,115  0,048  Bronchodilator
0,076  0,010  DNA-dependent protein kinase inhibitor
0,131  0,065  Vanilloid 1 agonist
0,181  0,115  Antineoplastic (lymphocytic leukemia)
0,122  0,058  Interleukin 8 antagonist
0,123  0,061  Alcohol dehydrogenase substrate
0,177  0,116  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,129  0,068  Cyclooxygenase 3 inhibitor
0,144  0,084  Movement disorders treatment
0,176  0,116  5 Hydroxytryptamine 3E antagonist
0,112  0,053  Toll-Like receptor 4 antagonist
0,081  0,023  Protease activated receptor antagonist
0,130  0,072  Cocaine dependence treatment
0,087  0,030  Potassium channel large-conductance Ca-activated activator
0,066  0,009  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,092  0,038  Thioredoxin reductase inhibitor
0,080  0,026  Neuraminidase inhibitor
0,070  0,018  Ryanodine receptor antagonist
0,128  0,078  CC chemokine 6 receptor antagonist
0,073  0,025  Heat shock protein 90 beta antagonist
0,086  0,039  GABA aminotransferase inhibitor
0,103  0,056  Sphingomyelinase inhibitor
0,074  0,028  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,097  0,052  Thioredoxin inhibitor
0,121  0,077  Antihyperlipoproteinemic
0,061  0,017  Cholesterol esterase inhibitor
0,209  0,166  Vasodilator, peripheral
0,052  0,008  Catechol O-methyltransferase inhibitor
0,082  0,039  Dopamine D2 antagonist
0,074  0,033  Aryl hydrocarbon receptor antagonist
0,096  0,056  Antiviral (Rhinovirus)
0,085  0,046  Na+ K+ transporting ATPase inhibitor
0,134  0,095  Phospholipase A2 inhibitor
0,052  0,013  Estrogen-related receptor alpha antagonist
0,106  0,067  DNA intercalator
0,131  0,093  Antianemic
0,112  0,075  Alkylator
0,109  0,073  TRPA1 agonist
0,059  0,024  Glucose-6-phosphate translocase inhibitor
0,106  0,071  Protein kinase (CK2) alpha inhibitor
0,117  0,083  Cyclooxygenase 2 inhibitor
0,044  0,011  Nucleoside transporters inhibitor
0,080  0,047  Dopamine antagonist
0,047  0,016  Inosine monophosphate dehydrogenase inhibitor
0,097  0,067  Anabolic
0,179  0,148  Huntington's disease treatment
0,101  0,071  Skin irritative effect
0,137  0,108  Muscular dystrophy treatment
0,099  0,071  Mediator release inhibitor
0,147  0,119  Psychostimulant
0,078  0,051  Narcotic antagonist
0,041  0,015  Melatonin 2 agonist
0,058  0,034  Carbonic anhydrase XII inhibitor
0,083  0,059  Antiviral (Trachoma)
0,082  0,059  Estrogen-related receptor beta agonist
0,042  0,019  Vanilloid 3 antagonist
0,124  0,101  Antidote
0,092  0,070  Phosphodiesterase 6D inhibitor
0,030  0,009  Dopamine D1 agonist
0,083  0,062  Androgen antagonist
0,058  0,037  Alcohol oxidase inhibitor
0,068  0,047  Endocannabinoid uptake inhibitor
0,044  0,023  Dopamine D5 agonist
0,051  0,031  Factor III inhibitor
0,051  0,031  Topoisomerase II beta inhibitor
0,032  0,012  Sodium/glucose cotransporter 2 inhibitor
0,068  0,048  Carbonic anhydrase VA inhibitor
0,037  0,017  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,036  0,016  Cholesterol ester transfer protein antagonist
0,088  0,069  Prolactin inhibitor
0,062  0,043  Antimycoplasmal
0,054  0,037  Leukotriene B4 antagonist
0,063  0,046  Neuraminidase (influenza) inhibitor
0,084  0,067  NADH dehydrogenase inhibitor
0,074  0,057  Antitreponemal
0,139  0,122  ATPase inhibitor
0,035  0,019  Melatonin receptor 1A agonist
0,066  0,052  Peroxisome proliferator-activated receptor gamma agonist
0,069  0,056  Peroxisome proliferator-activated receptor gamma antagonist
0,067  0,053  SULT2A1 substrate
0,180  0,167  Flavin-containing monooxygenase substrate
0,160  0,147  Immunostimulant
0,086  0,073  Glutamate release inhibitor
0,024  0,013  Estrone sulfatase inhibitor
0,101  0,089  Microtubule formation inhibitor
0,094  0,083  Antihelmintic (Fasciola)
0,022  0,011  Inosine monophosphate dehydrogenase 2 inhibitor
0,046  0,035  Peroxisome proliferator-activated receptor alpha agonist
0,047  0,036  Carbonic anhydrase XIV inhibitor
0,053  0,042  Carbonic anhydrase VB inhibitor
0,072  0,061  GABA B receptor agonist
0,026  0,016  Sodium/glucose cotransporter inhibitor
0,097  0,086  Antifungal (Aspergillus)
0,051  0,041  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,061  0,052  Carbonic anhydrase V inhibitor
0,057  0,047  Antidote, heavy metal
0,117  0,109  Diuretic
0,096  0,088  Adenylate cyclase inhibitor
0,060  0,052  Dopamine agonist
0,128  0,121  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,086  0,080  UDP-glucose 4-epimerase inhibitor
0,083  0,077  Restless leg syndrome treatment
0,120  0,116  Antidiarrheal
0,049  0,045  Vanilloid 2 antagonist
0,054  0,050  Androgen agonist
0,053  0,050  Pregnane X receptor antagonist
0,022  0,019  Protein 30S ribosomal subunit inhibitor
0,106  0,103  Toll-Like receptor 9 antagonist
0,060  0,057  Beta 3 adrenoreceptor antagonist
0,157  0,154  Myocardial infarction treatment
0,065  0,062  Glutamate decarboxylase inhibitor
0,018  0,016  Antibiotic Anthracycline-like
0,101  0,100  Alpha-N-acetylglucosaminidase inhibitor
0,062  0,061  Antihemophilic
0,056  0,054  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,056  0,055  Dopamine D1 antagonist
0,056  0,056  Nitric oxide donor

